Skip to main content
. 2023 Jan 20;14:1110624. doi: 10.3389/fendo.2023.1110624

Table 3.

Treatment-related adverse events of in patients.

Variable Group (n%) P value
GS+A group GS group
Gastrointestinal reaction 12 (40.0) 14 (34.2) 0.613
Hematological toxicity 11 (36.7) 10 (24.4) 0.263
Hepatotoxicity 7 (23.3) 5 (12.2) 0.216
Hand-foot syndrome 9(30.0) 10 (24.4) 0.598
Oral mucositis 4 (13.3) 6 (14.6) 0.876